... fishy? If this drug has such a great chance of being approved, why is the stock not up only 2 weeks away from verdict? Or, if the approval is such a sure thing, have we overestimated the drug? Insiders have been slowly selling above $10... that doesn't give much confidence. I would love to believe in this story, but something stinks. Or, perhaps, this will be the surprise of all surprises and people will be kicking themselves that they missed a no-brainer. We'll find out soon...